MarketPeel
Insider Trading Intelligence
ME

Michael James Elliott

IMVT
CHIEF SCIENTIFIC OFFICER · IMMUNOVANT, INC. · CIK 0001822515
FILING MIX · LIFETIME100%/0%
BUYS
3
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
97,600
AVG SELL PX
TRADE KIND
SHOWING 3 / 3
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Michael James Elliott. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
IMVT · 97,600 shares · as of Mar 19, 2021
0100,000200,000300,000400,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
FLOW · 3 buys / 0 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
342,300342,300Mar 19, 2021Mar 23, 2021
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
97,60097,600Mar 19, 2021Mar 23, 2021
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
400,000400,000Sep 4, 2020Sep 4, 2020
Other insiders · IMVT
Loading peer insiders…
About this filer
CIK 0001822515
ROLE
Chief Scientific Officer
PRIMARY
IMVT
COMPANIES
1
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001822515DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback